Stay updated on SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page.

Latest updates to the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page
- Check4 days agoChange DetectedThe page's revision tag has been updated to v3.6.5, replacing the previous v3.6.4, indicating a small editorial or system update to the study page.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a small update to the page metadata. This does not change the study details or how to participate.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedThe page metadata was updated from revision v3.6.2 to v3.6.3, indicating a behind-the-scenes update; the visible study information remains unchanged.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now shows revision v3.6.2, replacing the previous v3.6.0. This indicates a refreshed version of the study page has been published.SummaryDifference0.1%

- Check61 days agoChange DetectedThe Study Details page now indicates that recruitment is closed, and several navigation/help sections were added or clarified to improve access to the study information.SummaryDifference0.5%

- Check68 days agoChange DetectedThe page revision label has been updated to Revision: v3.5.5, replacing v3.5.4. This indicates a minor update to the page's revision history.SummaryDifference0.1%

Stay in the know with updates to SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page.